News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Conference News ESC 2024 New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document Caitlin E. Cox September 10, 2024
News Daily News AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care L.A. McKeown May 17, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Daily News PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis Caitlin E. Cox August 15, 2019
News Daily News Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data Caitlin E. Cox July 30, 2019
News Daily News DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms Caitlin E. Cox July 11, 2019
News Daily News FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One L.A. McKeown June 19, 2019
News Daily News US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions Caitlin E. Cox June 18, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Daily News A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex L.A. McKeown March 01, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Conference News VIVA 2018 No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018
News Daily News Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome Todd Neale December 08, 2017
News Daily News 3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort Michael O'Riordan July 11, 2017